{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:27:54Z","timestamp":1791224874422,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00702-014-1315-y","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T20:58:13Z","timestamp":1411073893000},"page":"607-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies"],"prefix":"10.1007","volume":"122","author":[{"given":"Chun-ling","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Faraz","family":"Kazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Grundke-Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"key":"1315_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00688184","volume":"74","author":"I Alafuzoff","year":"1987","unstructured":"Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 74:209\u2013225","journal-title":"Acta Neuropathol (Berl)"},{"key":"1315_CR2","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","volume":"91","author":"AD Alonso","year":"1994","unstructured":"Alonso AD, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91:5562\u20135566","journal-title":"Proc Natl Acad Sci USA"},{"key":"1315_CR3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","volume":"2","author":"AD Alonso","year":"1996","unstructured":"Alonso AD, Grundke-Iqbal I, Iqbal K (1996) Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783\u2013787","journal-title":"Nat Med"},{"key":"1315_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.cdd.4401314","volume":"11","author":"G Amadoro","year":"2004","unstructured":"Amadoro G, Serafino AL, Barbato C, Ciotti MT, Sacco A, Calissano P, Canu N (2004) Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cel Death Differ 11:217\u2013230. doi: 10.1038\/sj.cdd.4401314","journal-title":"Cel Death Differ"},{"key":"1315_CR5","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0511065103","volume":"103","author":"G Amadoro","year":"2006","unstructured":"Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N (2006) NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK\/MAPK activation. Proc Natl Acad Sci USA 103:2892\u20132897. doi: 10.1073\/pnas.0511065103","journal-title":"Proc Natl Acad Sci USA"},{"key":"1315_CR6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42:631\u2013639","journal-title":"Neurology"},{"key":"1315_CR7","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","volume":"27","author":"AA Asuni","year":"2007","unstructured":"Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115\u20139129","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"1315_CR8","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3233\/JAD-131832","volume":"40","author":"J Avila","year":"2014","unstructured":"Avila J, Simon D, Diaz-Hernandez M, Pintor J, Hernandez F (2014) Sources of extracellular tau and its signaling. J Alzheimers Dis 40(Suppl 1):S7\u2013S15. doi: 10.3233\/JAD-131832","journal-title":"J Alzheimers Dis"},{"key":"1315_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0003-2697(76)80064-4","volume":"70","author":"A Bensadoun","year":"1976","unstructured":"Bensadoun A, Weinstein D (1976) Assay of proteins in the presence of interfering materials. Anal Biochem 70:241\u2013250","journal-title":"Anal Biochem"},{"key":"1315_CR10","doi-asserted-by":"crossref","first-page":"e26860","DOI":"10.1371\/journal.pone.0026860","volume":"6","author":"M Bi","year":"2011","unstructured":"Bi M, Ittner A, Ke YD, Gotz J, Ittner LM (2011) Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS One 6:e26860. doi: 10.1371\/journal.pone.0026860","journal-title":"PLoS One"},{"key":"1315_CR11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.expneurol.2010.05.010","volume":"224","author":"M Boimel","year":"2010","unstructured":"Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H (2010) Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Exp Neurol 224:472\u2013485. doi: 10.1016\/j.expneurol.2010.05.010","journal-title":"Exp Neurol"},{"key":"1315_CR12","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","volume":"30","author":"A Boutajangout","year":"2010","unstructured":"Boutajangout A, Quartermain D, Sigurdsson EM (2010) Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J Neurosci 30:16559\u201316566. doi: 10.1523\/JNEUROSCI.4363-10.2010","journal-title":"J Neurosci"},{"key":"1315_CR13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","volume":"118","author":"A Boutajangout","year":"2011","unstructured":"Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM (2011) Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem 118:658\u2013667. doi: 10.1111\/j.1471-4159.2011.07337.x","journal-title":"J Neurochem"},{"key":"1315_CR14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351\u2013357","journal-title":"Neurobiol Aging"},{"key":"1315_CR15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-013-1139-0","volume":"126","author":"H Braak","year":"2013","unstructured":"Braak H, Zetterberg H, Del Tredici K, Blennow K (2013) Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-beta changes occur before increases of tau in cerebrospinal fluid. Acta Neuropathol 126:631\u2013641. doi: 10.1007\/s00401-013-1139-0","journal-title":"Acta Neuropathol"},{"key":"1315_CR16","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","volume":"34","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL et al (2014) Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci 34:4260\u20134272. doi: 10.1523\/JNEUROSCI.3192-13.2014","journal-title":"J Neurosci"},{"key":"1315_CR17","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","volume":"286","author":"X Chai","year":"2011","unstructured":"Chai X et al (2011) Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression. J Biol Chem 286:34457\u201334467. doi: 10.1074\/jbc.M111.229633","journal-title":"J Biol Chem"},{"key":"1315_CR18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909\u2013913","journal-title":"Nat Cell Biol"},{"key":"1315_CR19","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera F et al (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535\u20139540. doi: 10.1073\/pnas.1301175110","journal-title":"Proc Natl Acad Sci USA"},{"key":"1315_CR20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2007.06.013","volume":"28","author":"LK Clinton","year":"2007","unstructured":"Clinton LK et al (2007) Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 28:76\u201382","journal-title":"Neurobiol Dis"},{"key":"1315_CR21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2008.03.011","volume":"38","author":"V Corsetti","year":"2008","unstructured":"Corsetti V et al (2008) Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer\u2019s disease models. Mol Cell Neurosci 38:381\u2013392. doi: 10.1016\/j.mcn.2008.03.011","journal-title":"Mol Cell Neurosci"},{"key":"1315_CR22","doi-asserted-by":"crossref","first-page":"e62402","DOI":"10.1371\/journal.pone.0062402","volume":"8","author":"C d\u2019Abramo","year":"2013","unstructured":"d\u2019Abramo C, Acker CM, Jimenez HT, Davies P (2013) Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. PLoS One 8:e62402. doi: 10.1371\/journal.pone.0062402","journal-title":"PLoS One"},{"key":"1315_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2007.05.010","volume":"30","author":"F Denk","year":"2009","unstructured":"Denk F, Wade-Martins R (2009) Knock-out and transgenic mouse models of tauopathies. Neurobiol Aging 30:1\u201313. doi: 10.1016\/j.neurobiolaging.2007.05.010","journal-title":"Neurobiol Aging"},{"key":"1315_CR24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","volume":"36","author":"R D\u2019Hooge","year":"2001","unstructured":"D\u2019Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60\u201390","journal-title":"Brain Res Brain Res Rev"},{"key":"1315_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS et al (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370:311\u2013321. doi: 10.1056\/NEJMoa1312889","journal-title":"N Engl J Med"},{"key":"1315_CR26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4179","volume":"12","author":"MH Flight","year":"2013","unstructured":"Flight MH (2013) Neurodegenerative disease: tau immunotherapy targets transcellular propagation. Nat Rev Drug Discov 12:904. doi: 10.1038\/nrd4179","journal-title":"Nat Rev Drug Discov"},{"key":"1315_CR27","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845\u201312852. doi: 10.1074\/jbc.M808759200","journal-title":"J Biol Chem"},{"key":"1315_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2010.09.008","volume":"32","author":"S Garg","year":"2011","unstructured":"Garg S, Timm T, Mandelkow EM, Mandelkow E, Wang Y (2011) Cleavage of Tau by calpain in Alzheimer\u2019s disease: the quest for the toxic 17 kD fragment. Neurobiol Aging 32:1\u201314. doi: 10.1016\/j.neurobiolaging.2010.09.008","journal-title":"Neurobiol Aging"},{"key":"1315_CR29","author":"E Giacobini","year":"2013","unstructured":"Giacobini E, Gold G (2013) Alzheimer disease therapy-moving from amyloid-beta to tau. Nat Rev Neurol. doi: 10.1038\/nrneurol.2013.223","journal-title":"Nat Rev Neurol"},{"key":"1315_CR30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology 60:1495\u20131500","journal-title":"Neurology"},{"key":"1315_CR31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"1315_CR32","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913\u20134917","journal-title":"Proc Natl Acad Sci USA"},{"key":"1315_CR33","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","volume":"288","author":"J Gu","year":"2013","unstructured":"Gu J, Congdon EE, Sigurdsson EM (2013) Two novel Tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce Tau protein pathology. J Biol Chem 288:33081\u201333095. doi: 10.1074\/jbc.M113.494922","journal-title":"J Biol Chem"},{"key":"1315_CR34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C et al (2008) Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372:216\u2013223","journal-title":"Lancet"},{"key":"1315_CR35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(86)92134-3","volume":"2","author":"K Iqbal","year":"1986","unstructured":"Iqbal K et al (1986) Defective brain microtubule assembly in Alzheimer\u2019s disease. Lancet 2:421\u2013426","journal-title":"Lancet"},{"key":"1315_CR36","author":"SF Kazim","year":"2014","unstructured":"Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K (2014) Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis. doi: 10.1016\/j.nbd.2014.07.001","journal-title":"Neurobiol Dis"},{"key":"1315_CR37","doi-asserted-by":"crossref","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","volume":"268","author":"E Kopke","year":"1993","unstructured":"Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374\u201324384","journal-title":"J Biol Chem"},{"key":"1315_CR38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/ITT.S31428","volume":"2013","author":"D Lambracht-Washington","year":"2013","unstructured":"Lambracht-Washington D, Rosenberg RN (2013) Anti-amyloid beta to tau-based immunization: developments in immunotherapy for Alzheimer disease. Immuno Targets Ther 2013:105\u2013114. doi: 10.2147\/ITT.S31428","journal-title":"Immuno Targets Ther"},{"key":"1315_CR39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.1996.tb34407.x","volume":"777","author":"EM Mandelkow","year":"1996","unstructured":"Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, Trinczek B, Mandelkow E (1996) Structure, microtubule interactions, and phosphorylation of tau protein. Ann N Y Acad Sci 777:96\u2013106","journal-title":"Ann N Y Acad Sci"},{"key":"1315_CR40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah E et al (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46:857\u2013868. doi: 10.1016\/j.neuron.2005.05.010","journal-title":"Neuron"},{"key":"1315_CR41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","volume":"297","author":"RG Morris","year":"1982","unstructured":"Morris RG, Garrud P, Rawlins JN, O\u2019Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681\u2013683","journal-title":"Nature"},{"key":"1315_CR42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","volume":"24","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003a) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease. Neurobiol Aging 24:1063\u20131070","journal-title":"Neurobiol Aging"},{"key":"1315_CR43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S et al (2003b) Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409\u2013421","journal-title":"Neuron"},{"key":"1315_CR44","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1523\/JNEUROSCI.1125-05.2005","volume":"25","author":"SY Park","year":"2005","unstructured":"Park SY, Ferreira A (2005) The generation of a 17\u00a0kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25:5365\u20135375. doi: 10.1523\/JNEUROSCI.1125-05.2005","journal-title":"J Neurosci"},{"key":"1315_CR45","doi-asserted-by":"crossref","first-page":"e23865","DOI":"10.1371\/journal.pone.0023865","volume":"6","author":"JB Reinecke","year":"2011","unstructured":"Reinecke JB et al (2011) Implicating calpain in tau-mediated toxicity in vivo. PloS One 6:e23865. doi: 10.1371\/journal.pone.0023865","journal-title":"PloS One"},{"key":"1315_CR46","first-page":"369808","volume":"2012","author":"C Reitz","year":"2012","unstructured":"Reitz C (2012) Alzheimer\u2019s disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis 2012:369808. doi: 10.1155\/2012\/369808","journal-title":"Int J Alzheimers Dis"},{"key":"1315_CR47","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science 316:750\u2013754","journal-title":"Science"},{"key":"1315_CR48","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1523\/JNEUROSCI.2514-06.2006","volume":"26","author":"ER Rosario","year":"2006","unstructured":"Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ (2006) Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 26:13384\u201313389. doi: 10.1523\/JNEUROSCI.2514-06.2006","journal-title":"J Neurosci"},{"key":"1315_CR49","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.63.10.1459","volume":"63","author":"H Rosenmann","year":"2006","unstructured":"Rosenmann H, Grigoriadis N, Karussis D, Boimel M, Touloumi O, Ovadia H, Abramsky O (2006) Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. Arch Neurol 63:1459\u20131467. doi: 10.1001\/archneur.63.10.1459","journal-title":"Arch Neurol"},{"key":"1315_CR50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S et al (2014) Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370:322\u2013333. doi: 10.1056\/NEJMoa1304839","journal-title":"N Engl J Med"},{"key":"1315_CR51","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders DW et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271\u20131288. doi: 10.1016\/j.neuron.2014.04.047","journal-title":"Neuron"},{"key":"1315_CR52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-2008-15202","volume":"15","author":"EM Sigurdsson","year":"2008","unstructured":"Sigurdsson EM (2008) Immunotherapy targeting pathological tau protein in Alzheimer\u2019s disease and related tauopathies. J Alzheimers Dis 15:157\u2013168","journal-title":"J Alzheimers Dis"},{"key":"1315_CR53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580","journal-title":"Ann Neurol"},{"key":"1315_CR54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","volume":"9","author":"W Thies","year":"2013","unstructured":"Thies W, Bleiler L, Alzheimer\u2019s A (2013) 2013 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 9:208\u2013245. doi: 10.1016\/j.jalz.2013.02.003","journal-title":"Alzheimers Dement"},{"key":"1315_CR55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0022-510X(70)90063-8","volume":"11","author":"BE Tomlinson","year":"1970","unstructured":"Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11:205\u2013242","journal-title":"J Neurol Sci"},{"key":"1315_CR56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720512800492503","volume":"9","author":"L Troquier","year":"2012","unstructured":"Troquier L et al (2012) Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res 9:397\u2013405","journal-title":"Curr Alzheimer Res"},{"key":"1315_CR57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00308476","volume":"83","author":"PG Vallet","year":"1992","unstructured":"Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease. Acta Neuropathol 83:170\u2013178","journal-title":"Acta Neuropathol"},{"key":"1315_CR58","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848\u2013858. doi: 10.1038\/nprot.2006.116","journal-title":"Nat Protoc"},{"key":"1315_CR59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt237","volume":"6","author":"B Winblad","year":"2014","unstructured":"Winblad B, Graf A, Riviere ME, Andreasen N, Ryan JM (2014) Active immunotherapy options for Alzheimer\u2019s disease. Alzheimers Res Ther 6:7. doi: 10.1186\/alzrt237","journal-title":"Alzheimers Res Ther"},{"key":"1315_CR60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K et al (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80:402\u2013414. doi: 10.1016\/j.neuron.2013.07.046","journal-title":"Neuron"},{"key":"1315_CR61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2008-15203","volume":"15","author":"N Zilka","year":"2008","unstructured":"Zilka N, Kontsekova E, Novak M (2008) Chaperone-like antibodies targeting misfolded tau protein: new vistas in the immunotherapy of neurodegenerative foldopathies. J Alzheimers Dis 15:169\u2013179","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1315-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-014-1315-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-014-1315-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T10:43:03Z","timestamp":1650192183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-014-1315-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1315"],"URL":"https:\/\/doi.org\/10.1007\/s00702-014-1315-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}